Pathology Measures 2025

  • CAP 30: Urinary Bladder Cancer: Complete Analysis and Timely Reporting
  • CAP 34: Molecular Assessment: Biomarkers in Non-Small Lung Cancer
  • CAP 40: Squamous Cell Skin Cancer: Complete Reporting
  • CAP 42: Barrett’s Esophagus: Complete Analysis with Appropriate Consultation
  • CAP 43: Complete Reporting of Gastrointestinal Metaplasia
  • CAP 44: Molecular Assessment for Endometrial Carcinoma
  • QPP 249: Barrett’s Esophagus
  • QPP 250: Radical Prostatectomy Pathology Reporting
  • QPP 395: Lung Cancer Reporting (Biopsy/Cytology Specimens)
  • QPP 396: Lung Cancer Reporting (Resection Specimens)
  • QPP 397: Melanoma Reporting
  • QPP 440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician
  • QPP 491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status